Scientists test new Drug's safety in people with liver issues
NCT ID NCT06619054
Summary
This study tested how a new drug called KP-001 is processed by the body in people with different levels of liver problems. Researchers gave a single dose to 24 adults, including healthy volunteers and people with mild to severe liver impairment. The goal was to see if liver problems change how the drug works in the body and to check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sites contracted by Parexel
San Antonio, Texas, 08103, United States
Conditions
Explore the condition pages connected to this study.